Nephro Care India Limited (NSE:NEPHROCARE)
68.85
+0.80 (1.18%)
At close: Jun 17, 2026
Nephro Care India Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 64.86 | 46.58 | 12.91 | 23.17 | 6.09 |
Short-Term Investments | 100.16 | 160 | 65.1 | - | - |
Cash & Short-Term Investments | 165.02 | 206.58 | 78 | 23.17 | 6.09 |
Cash Growth | -20.12% | 164.84% | 236.72% | 280.39% | 26.30% |
Accounts Receivable | 60.43 | 32.26 | 1.54 | 0.43 | 1.93 |
Other Receivables | - | - | 0.64 | - | 0.61 |
Receivables | 60.81 | 32.26 | 2.18 | 0.43 | 2.54 |
Inventory | 22.88 | 12.26 | 3.52 | 4.84 | 1.71 |
Other Current Assets | 59.15 | 31.26 | 25.35 | 0.99 | 0.51 |
Total Current Assets | 307.86 | 282.36 | 109.06 | 29.44 | 10.84 |
Property, Plant & Equipment | 344.36 | 320.79 | 55.93 | 30.13 | 32.92 |
Long-Term Investments | 17.47 | 25.84 | - | 20 | 0.25 |
Other Intangible Assets | 1.09 | - | - | - | - |
Long-Term Deferred Tax Assets | - | - | 0.85 | 0.92 | - |
Other Long-Term Assets | 39.49 | 53.86 | 43.84 | 2.1 | 2.28 |
Total Assets | 727.21 | 682.85 | 209.67 | 82.59 | 46.29 |
Accounts Payable | 67.05 | 38.36 | 18.74 | 9.39 | 4.61 |
Accrued Expenses | - | 88.66 | 21.93 | 15.27 | 1.15 |
Current Portion of Long-Term Debt | - | - | - | 0.43 | 0.74 |
Current Income Taxes Payable | - | 9.8 | 17.94 | 7.83 | - |
Current Unearned Revenue | - | 3.5 | 0.03 | - | - |
Other Current Liabilities | 85.7 | - | - | - | 9.99 |
Total Current Liabilities | 152.75 | 140.31 | 58.64 | 32.92 | 16.48 |
Long-Term Debt | - | - | - | 24.39 | 24.64 |
Pension & Post-Retirement Benefits | - | 1.7 | 0.51 | - | 0.15 |
Long-Term Deferred Tax Liabilities | 1.38 | 3.02 | - | - | 0.07 |
Other Long-Term Liabilities | 4.05 | 2.97 | 0.27 | - | - |
Total Liabilities | 158.18 | 148 | 59.42 | 57.3 | 41.34 |
Common Stock | 164.86 | 164.86 | 119.02 | 5 | 5 |
Retained Earnings | - | 369.98 | 31.23 | 20.29 | -0.05 |
Comprehensive Income & Other | 403.67 | - | - | - | - |
Total Common Equity | 568.54 | 534.85 | 150.25 | 25.29 | 4.95 |
Minority Interest | 0.49 | - | - | - | - |
Shareholders' Equity | 569.03 | 534.85 | 150.25 | 25.29 | 4.95 |
Total Liabilities & Equity | 727.21 | 682.85 | 209.67 | 82.59 | 46.29 |
Total Debt | - | - | - | 24.82 | 25.37 |
Net Cash (Debt) | 165.02 | 206.58 | 78 | -1.65 | -19.28 |
Net Cash Growth | -20.12% | 164.84% | - | - | - |
Net Cash Per Share | 9.99 | 13.52 | 6.59 | -0.16 | -5.42 |
Filing Date Shares Outstanding | 5.94 | 16.49 | 11.9 | 10 | 10 |
Total Common Shares Outstanding | 5.94 | 16.49 | 11.9 | 10 | 10 |
Working Capital | 155.11 | 142.05 | 50.41 | -3.48 | -5.64 |
Book Value Per Share | 95.71 | 32.44 | 12.62 | 2.53 | 0.50 |
Tangible Book Value | 567.45 | 534.85 | 150.25 | 25.29 | 4.95 |
Tangible Book Value Per Share | 95.53 | 32.44 | 12.62 | 2.53 | 0.50 |
Machinery | - | 204.66 | 32.92 | 22.5 | 15.2 |
Construction In Progress | - | 5.94 | 8.58 | - | 18.99 |
Leasehold Improvements | - | 149.21 | 28.85 | 16.73 | - |